$4.59
-0.36-7.27%
At close: Dec 16, 4:00 PM EST
$4.63
0.040.87%
After Hours: 6:45 PM EST
Comments
Loading...
Arbutus Biopharma Earnings Estimates, EPS & Revenue | NASDAQ:ABUS | Benzinga
Arbutus Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-0.040
Quarterly Revenue
$529.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$14.61M
Analyze the earnings history of Arbutus Biopharma using advanced sorting and filters.
Arbutus Biopharma (ABUS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-13 | $-0.04 | $-0.04 | 0.00 % |
| Q2 | 2025-08-06 | $0.01 | $-0.06 | 116.7 % |
| Q1 | 2025-05-14 | $-0.13 | $-0.15 | 13.3 % |
| Q4 | 2025-03-27 | $-0.07 | $-0.12 | 41.7 % |
Arbutus Biopharma (ABUS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-13 | $529.00K | $1.31M | -59.6 % |
| Q2 | 2025-08-06 | $10.74M | $2.05M | 424.4 % |
| Q1 | 2025-05-14 | $1.76M | $2.29M | -23.0 % |
| Q4 | 2025-03-27 | $1.57M | $2.21M | -28.8 % |
FAQ
When is Arbutus Biopharma (NASDAQ:ABUS) reporting earnings?
Arbutus Biopharma (ABUS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2025 for Q3.
What were the latest earnings per share (EPS) for Arbutus Biopharma (NASDAQ:ABUS)?
Arbutus Biopharma (ABUS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2025 for Q3 and the Actual EPS was $-0.04, which hit the estimate of $-0.04.
What were Arbutus Biopharma’s (NASDAQ:ABUS) revenues?
Arbutus Biopharma (ABUS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2025 for Q3 and the Actual Revenue was $529K, which missed the estimate of $1.3M.
Browse earnings estimates, EPS, and revenue on all stocks.
